Liver Transplantation and Metastatic Colo-rectal Cancer.
NCT ID: NCT00294827
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE2
25 participants
INTERVENTIONAL
2006-02-28
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases
NCT03488953
Liver Transplantation and Colorectal Cancer
NCT01479608
Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
NCT03494946
Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases
NCT02864485
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
NCT05248581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liver transplantation
Liver transplantation and colo-rectal cancer
Liver transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liver transplantation and colo-rectal cancer
Liver transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Magnus Smedman, MD
Consultant, gastrointestinal oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Svein Dueland, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Rikshospitalet-Radiumhospitalet RRHF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rikshospitalet-Radiumhospitalet HF
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Foss A, Adam R, Dueland S. Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int. 2010 Jul;23(7):679-85. doi: 10.1111/j.1432-2277.2010.01097.x. Epub 2010 Apr 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-05409 (SECA I)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.